Because most malignant tumor cells express PD-L1, binding to PD-1 expressed on the surface of T cells drastically reduces cytokine production as well as T cell proliferation and activity, eventually leading to immunological resistance/evasion. The gene discussed is PDCD1; the disease is neoplasm.